PepGen (PEPG) Amortizatization of Intangibles (2024 - 2026)
PepGen (PEPG) posted Amortizatization of Intangibles of $822000.0 for Q1 2026, up 18.1% sequentially from $696000.0 in Q1 2025, and up 18.1% YoY from $696000.0 in Q1 2025.
Analysis
PepGen (PEPG) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
PepGen has reported Amortizatization of Intangibles for 3 years, with the latest figure at $822000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles rose 18.1% year-over-year to $822000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (changed N/A YoY) and the FY2025 annual result came in at $2.2 million, down 43.64% from the prior year.
- Amortizatization of Intangibles improved to $822000.0 in Q1 2026 per PEPG's latest filing, from $696000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $1.0 million in Q4 2024 and troughed at $516000.0 in Q1 2024.
- A 3-year average of $763500.0 and a median of $759000.0 in 2025 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2025 and 2026: Amortizatization of Intangibles surged 34.88% in 2025, then advanced 18.1% in 2026.
- Over 3 years, Amortizatization of Intangibles stood at $1.0 million in 2024, then slumped by 31.76% to $696000.0 in 2025, then rose by 18.1% to $822000.0 in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $822000.0, $696000.0, and $1.0 million for Q1 2026, Q1 2025, and Q4 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | PepGen | 217.99 Mn | 217.99 Mn | - | 892,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 892,000.00 |
| Mar 31, 2026 | 822,000.00 |
| Jun 30, 2025 | 454,000.00 |
| Mar 31, 2025 | 696,000.00 |
| Dec 31, 2024 | 1.02 Mn |
| Mar 31, 2024 | 516,000.00 |